Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3763220019 | Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3763221015 | Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
468977014 | Zinc undecenoate+undecenoic acid 20/5% powder | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
468977014 | Zinc undecenoate+undecenoic acid 20/5% powder | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
721897019 | Zinc undecenoate+undecenoic acid 20/5% powder (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1192882014 | Zinc undecenoate+undecenoic acid 20/5% powder (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1192882014 | Zinc undecenoate+undecenoic acid 20/5% powder (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3763220019 | Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3763221015 | Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Is a | Product containing undecenoate (product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Undecenoate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Is a | Product containing undecylenic acid and zinc undecylenate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Undecylenic acid and zinc undecylenate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | forme pharmaceutique pour usage transdermique et/ou cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Is a | Topical antifungal | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Zinc undecylenate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Undecylenic acid (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | Cutaneous powder | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Is a | Topical zinc | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Is a | Product containing only undecylenic acid in cutaneous dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Zinc undecylenate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Zinc undecylenate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Undecylenic acid (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Undecylenic acid (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Is a | Product containing undecylenic acid in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Plays role | Antifungal therapeutic role (role) | false | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets